Product Details
Place of Origin: China
Brand Name: Quickoolchem
Payment & Shipping Terms
Minimum Order Quantity: 50 grams
Price: Negotiable
Packaging Details: 1kg/Bag; 25kg/Carton
Delivery Time: 2-3 days
Payment Terms: T/T, Western Union, MoneyGram
Supply Ability: 10 MT/Month
Purity: |
≥99% |
Molecular Formula: |
C13H19N3O7 |
Density: |
1.46 G/cm3 |
Cas Number: |
2349386-89-4 |
Flash Point: |
316.5°C |
Storage: |
Store At -20°C |
Refractive Index: |
1.617 |
Appearance: |
White To Off-white Powder |
Origin: |
China |
Package: |
1kg/bag, 25kg/drum |
Purity: |
≥99% |
Molecular Formula: |
C13H19N3O7 |
Density: |
1.46 G/cm3 |
Cas Number: |
2349386-89-4 |
Flash Point: |
316.5°C |
Storage: |
Store At -20°C |
Refractive Index: |
1.617 |
Appearance: |
White To Off-white Powder |
Origin: |
China |
Package: |
1kg/bag, 25kg/drum |
Molnupiravir is an antiviral medication that gained attention during the COVID-19 pandemic. It was initially developed for the treatment of influenza. Molnupiravir works by introducing errors into the genetic material of viruses, which can prevent them from replicating effectively. This mechanism of action makes it potentially effective against a broad range of RNA viruses, including SARS-CoV-2, the virus responsible for COVID-19.
Clinical trials have been conducted to assess its efficacy and safety in treating COVID-19. Initial results suggested that it could reduce the risk of hospitalization and death in patients with mild to moderate COVID-19. However, like any medication, it also carries potential side effects and interactions, which need to be carefully evaluated.
| Purity | 99%min |
| Boiling Point: | ~600.3°C At 760 MmHg |
| Density: | 1.46 G/cm3 |
| Appearance: | White To Off-white Powder |
| Storage: | Store At -20°C |
| Purity: | ≥99% |
| Refractive Index: | 1.617 |
| Synonyms: | EIDD-2801; MK-4482; Molnupiravir Prodrug |
| Cas Number: | 2349386-89-4 |
This antiviral medication is suitable for various application occasions and scenarios. It can be used in hospitals, clinics, research institutions, and pharmaceutical companies. Molnupiravir EIDD-2801(New) can be used in the treatment of COVID-19 patients with mild and moderate symptoms. It can also be used for people who have been in contact with COVID-19 patients as a preventive measure.
1~25kgs packaging: Aluminium bag inside, Carton box outside.
25kgs packaging: Plastic bag inside, Fiber drum outside
